Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy (TTR-FAP)

被引：0

作者：

Conceicao, I. ^{[1
,2
]}

Gonzalez Duarte, A. ^{[3
]}

Obici, L. ^{[4
]}

Schmidt, H. ^{[5
]}

Simoneau, D. ^{[6
]}

Ong, M. -L. ^{[7
]}

Amass, L. ^{[8
]}

机构：

[1] Hosp Santa Maria, CHLN, Lisbon, Portugal

[2] IMM, Fac Med, Inst Physiol, Clin & Translat Physiol Unit, Lisbon, Portugal

[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[4] Fdn IRCCS Policlin, Amyloidosis Res & Treatment Ctr, Pavia, Italy

[5] Univ Klinikum Munster, Munster, Germany

[6] Pfizer Inc, Paris, France

[7] Pfizer Inc, New York, NY USA

[8] Pfizer Inc, Collegeville, PA USA

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2015年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1184

引用

页码：167 / 167

页数：1

共 50 条

[21] Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
Manuel Raya-Cruz
Juan Buades-Reines
Cristina Gallego-Lezaun
Ignacio Ferullo
Tomas Ripoll-Vera
Mercedes Uson-Martín
Hernan Andreu-Serra
Orphanet Journal of Rare Diseases, 10 (Suppl 1)
[22] LONG-TERM EFFECTS OF TAFAMIDIS - A NEW THERAPEUTIC OPTION FOR PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP)
Coelho, T.
Maia, L.
Martins da Silva, A.
Waddington Cruz, M.
Plante-Bordeneuve, V.
Suhr, O. B.
Conceicao, I.
Schmidt, H.
Trigo, P.
Packman, J.
Harnett, M.
Grogan, D. R.
JOURNAL OF HEPATOLOGY, 2012, 56 : S543 - S543
[23] Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
Buades-Reines, Juan
Raya-Cruz, Manuel
Gallego-Lezaun, Cristina
Ripoll-Vera, Tomas
Uson-Martin, Mercedes
Andreu-Serra, Hernan
Cisneros-Barroso, Eugenia
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (04) : 352 - 356
[24] Transthyretin amyloid cardiomyopathy: Literature review and red-flag symptom clusters for each cardiology specialty
Izumiya, Yasuhiro
Kubo, Toru
Endo, Jin
Takashio, Seiji
Minamisawa, Masatoshi
Hamada, Jun
Ishii, Tomonori
Abe, Hajime
Konishi, Hiroaki
Tsujita, Kenichi
ESC HEART FAILURE, 2025, 12 (02): : 955 - 967
[25] Validity and reliability of the Transthyretin Amyloidosis Neuropathy Score (TTR-ANS): a new outcome measure designed specifically for Familial Amyloid Polyneuropathy (TTR-FAP)
Monteiro, C.
Rodrigues, C.
Fernandes, J.
Cardoso, M.
Alves, C.
da Silva, A. Martins
Coelho, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 56 - 56
[26] Vitreous amyloid is formed by transthyretin (TTR) from the retina in familial amyloidotic polyneuropathy (FAP)
Ando, Y
Ando, E
Haraoka, K
Fukushima, M
Obayashi, K
Nakamura, M
Terazaki, H
Uchino, M
Okabe, H
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 108 - 108
[27] Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
Sebastián E Azorín Contesse
Christopher Cabib
Josep M Campistol
Orphanet Journal of Rare Diseases, 10 (Suppl 1)
[28] Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
Marta Lipowska
Dorota Rowczenio
Janet Gilbertson
Philip N Hawkins
Agnieszka Ptasinska-Perkowska
Hanna Drac
Orphanet Journal of Rare Diseases, 10 (Suppl 1)
[29] Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm
Inomata, Takayuki
Tahara, Nobuhiro
Nakamura, Kazufumi
Endo, Jin
Ueda, Mitsuharu
Ishii, Tomonori
Kitano, Yoshinobu
Koyama, Jun
ESC HEART FAILURE, 2021, 8 (04): : 2647 - 2659
[30] Identification of 3 new variants of the transthyretin (TTR) and study of haplotypes in familial amyloid polyneuropathy (FAP)
Bordeneuve, VP
Bicetre, LEK
Lalu, T
Misrahi, M
Said, G
NEUROLOGY, 1997, 48 (03) : 6089 - 6089

← 1 2 3 4 5 →